N2-Trityl Olmesartan Acid CAS 752179-89-8 Purity >98.0% (HPLC) Olmesartan Medoxomil Intermediate Factory

Short Description:

Chemical Name: N2-Trityl Olmesartan Acid 

CAS: 752179-89-8

Purity: >98.0% (HPLC) 

Appearance: White to Off-White Powder

Intermediate of Olmesartan Medoxomil  

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Chemical Properties:

Chemical Name N2-Trityl Olmesartan Acid
Synonyms Trityl Olmesartan Acid (N2); Olmesartan N2-Trityl Impurity; 4-(1-Hydroxy-1-Methylethyl)-2-Propyl-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-Imidazole-5-Carboxylic Acid; 4-(2-Hydroxypropan-2-yl)-2-Propyl-1-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-Imidazole-5-Carboxylic Acid
CAS Number 752179-89-8
CAT Number RF-PI1876
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C43H40N6O3
Molecular Weight 688.82
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance White to Off-White Powder 
Purity / Analysis Method >98.0% (HPLC)   
Loss on Drying <1.00%
Residue on Ignition <0.50%
Single Impurity <1.00%
Total Impurities <2.00%
Heavy Metals (as Pb) <20ppm
Test Standard Enterprise Standard
Usage Intermediate of Olmesartan Medoxomil (CAS: 144689-63-4)

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture

Advantages:

1

FAQ:

Application:

N2-Trityl Olmesartan Acid (CAS: 752179-89-8) is an intermediate in the synthesis of Olmesartan Medoxomil (CAS: 144689-63-4) related compounds. Olmesartan Medoxomil is an angiotensin II receptor antagonist which has been used for the treatment of high blood pressure. Olmesartan Medoxomil is a prodrug of Olmesartan, is an angiotensin II type 1 receptor (AT1) inhibitor that inhibits negative regulatory feedback on renin secretion, decreasing secretion of aldosterone and resulting in decreased peripheral vascular resistance (vasodilation). This compound exhibits antihypertensive, cardioprotective, vasodilatory, and anti-inflammatory activities. Olmesartan Medoxomil may be used alone or in combination with other antihypertensive agents. In comparative clinical studies in patients with essential hypertension, Olmesartan reduced sitting cuff diastolic blood pressure significantly more than Losartan, Valdesartan and Ibesartan, while reductions in systolic blood pressure were similar for all treatments.

  • Write your message here and send it to us